GM2-gangliosidosis Hexosaminidase mutations not of the Tay-Sachs type procedure unusual clinical variants
GM2-gangliosidosis Hexosaminidase mutations not of the Tay-Sachs type procedure unusual clinical variants
复制标题
GM2-神经节苷脂沉积症己糖胺酶突变不是 Tay-Sachs 型手术的异常临床变异
DOI:
10.1016/0166-2236(83)90008-5
复制
发表时间:
1983
影响因子:
15.9
通讯作者:
S. Raghavan
中科院分区:
文献类型:
--
作者:
E. Kolodny;S. Raghavan
The enzymatic hydrolysis of GM~-ganglioside* requires hexos~ e A and an activator protein. Mutations affecting the~ and B-chains of hexosaminidase A and the activator protein cause this glycolipid to accumulate in Tay-Sachs disease, Sandhoff disease and the AB variant, respectively. Juvenile and adult forms of these diseases appear to have slightly greater amounts of residual enzyme activity. Discrepancies between hexosaminidase A activity toward artificial substrates and GM~ ganglioside can be evaluated in situ by a tissue culture technique utilizing radioactively labelled Gu2-ganglioside. The variety of mutations affecting hexosaminidase A activity, and GM2-ganglioside hydrolysis has implications for Tay-Sachs disease carrier screening and prenatatdiagnosis. Future research on the GM2-gangliosidoses is likely to focus on the molecular defects in the polypeptide chain structure and ultimately, the gene sequence of the hexosaminidases.Tay-Sachs disease is a well= known hereditable cause of neurodegenerative disease of infancyt In the first 6 months, the child's physical appearance is normal but there is already an exaggerated startle reaction present. Subsequently, developmental delay occurs, and at the age of I year, voluntary movements are lost and seizures develop. Blindness' follows, the head size increases
DOI:
10.1016/0006-291x(81)91285-7
发表时间:
1981
影响因子:
3.1
作者:
Li,SC;Hirabayashi,Y;Li,YT
通讯作者:
Li,YT